+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Acute Repetitive Seizures Market Size, Share & Trends Analysis Report by Product (USL-261, NRL-1, AZ-002), Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 87 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 4700906
Description Jump to:
The global acute repetitive seizures market size is expected to reach USD 6.31 billion by 2030, according to the report. The report also states that the market will expand at a strong CAGR of 12.4% during the forecast period. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Acute Repetitive Seizures Market Report Highlights

  • Global acute repetitive seizures market size was estimated at USD 2.60 billion in 2022 and is expected to register a CAGR of 12.4% over the forecast period
  • The USL-261 segment dominated the market with the largest revenue share in 2022 because a caregiver can administer it without the need for a needle, and it works quickly.
  • North America held the largest share in 2022 due to factors, such as growing initiatives for raising awareness about epilepsy and seizures
  • Germany is expected to witness robust growth over the forecast period owing to technological advancements in scientific, clinical, and medical fields.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Acute Repetitive Seizures Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Acute Repetitive Seizures Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Acute Repetitive Seizures Market: Product Estimates & Trend Analysis
4.1. Acute Repetitive Seizures Market: Key Takeaways
4.2. Acute Repetitive Seizures Market: Movement & Market Share Analysis, 2022 & 2030
4.3. USL-261
4.3.1. USL-261 market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. NRL-1
4.4.1. NRL-1 market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. AZ-002
4.5.1. AZ-002 market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Diastat Rectal Gel
4.6.1. Diastat rectal gel market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Acute Repetitive Seizures Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Acute Repetitive Seizure market by Region: Key Takeaway
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Participants
6.2. Company/Competition Categorization
6.2.1. UCB S.A. Belgium
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Neurelis
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Bausch Health Companies Inc.
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. ALEXZA
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. VERITON PHARMA
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 3 North America acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 5 Canada acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 6 Europe acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 7 Europe acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 8 Germany acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 9 UK acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 10 France acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 11 Italy acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 12 Spain acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 13 Sweden acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 14 Norway acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 15 Denmark acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 16 Asia Pacific acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 17 Asia Pacific acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 18 Japan acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 19 China acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 20 India acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 21 Australia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 22 Thailand acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 23 South Korea acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 25 Latin America acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 27 Mexico acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 28 Argentina acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 33 UAE acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
Table 34 Kuwait acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Acute repetitive seizure: market outlook
Fig. 9 Acute repetitive seizure competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Acute repetitive seizures market driver impact
Fig. 15 Acute repetitive seizures market restraint impact
Fig. 16 Acute repetitive seizures market strategic initiatives analysis
Fig. 17 Acute repetitive seizures market: Product movement analysis
Fig. 18 Acute repetitive seizures market: Product outlook and key takeaways
Fig. 19 USL-261 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 NRL-1 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 AZ-002 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Diastat rectal gel market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Acute repetitive seizures market: Regional movement analysis
Fig. 25 Acute repetitive seizures market: Regional outlook and key takeaways
Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Profiled

  • UCB S.A. Belgium
  • Neurelis
  • Bausch Health Companies Inc.
  • ALEXZA
  • VERITON PHARMA

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Acute Repetitive Seizures Market by Product (AZ-002, Diastat Rectal Gel, NRL-1), End-use (Clinics, Hospital) - Forecast 2024-2030 - Product Image

Global Acute Repetitive Seizures Market by Product (AZ-002, Diastat Rectal Gel, NRL-1), End-use (Clinics, Hospital) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Global Acute Repetitive Seizures Market - Product Image

Global Acute Repetitive Seizures Market

  • Report
  • 200 Pages
  • Global
From
Acute Repetitive Seizures Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, & Forecast 2023-2030 - (By Drug Type Coverage, Route of Administration Coverage, Distribution Channel Coverage, End-use Coverage, Geographic Coverage & Leading Companies) - Product Image

Acute Repetitive Seizures Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, & Forecast 2023-2030 - (By Drug Type Coverage, Route of Administration Coverage, Distribution Channel Coverage, End-use Coverage, Geographic Coverage & Leading Companies)

  • Report
  • 240 Pages
  • Global
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2024-2032 - Product Image

Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.